BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 17476163)

  • 1. Basal-prandial insulin: when is the right time to initiate treatment?
    Kruger DF
    Nurse Pract; 2007 May; 32(5):24-9; quiz 29-30. PubMed ID: 17476163
    [No Abstract]   [Full Text] [Related]  

  • 2. Combination therapy in NIDDM.
    Raskin P
    N Engl J Med; 1992 Nov; 327(20):1453-4. PubMed ID: 1406863
    [No Abstract]   [Full Text] [Related]  

  • 3. Insulin-dependent diabetes of pregnancy treated with the combination of sulfonylurea and insulin.
    Ravina A
    Isr J Med Sci; 1995 Oct; 31(10):623-5. PubMed ID: 7591687
    [No Abstract]   [Full Text] [Related]  

  • 4. [Insulin or insulin + oral hypoglycemic drugs in the treatment of type 2 diabetes difficult to compensate metabolically?].
    Carta Q; Trovati M; Dani F; Caselle MT; Vitali S; Cavalot F; Rocca G; Cantino G; Mularoni E; Libertucci D
    Minerva Endocrinol; 1984; 9(2):241-5. PubMed ID: 6390138
    [No Abstract]   [Full Text] [Related]  

  • 5. Insulin therapy in type 2 diabetes.
    Wyne KL; Mora PF
    Endocr Res; 2007; 32(3):71-107. PubMed ID: 18092196
    [No Abstract]   [Full Text] [Related]  

  • 6. Insulin intensification strategies in type 2 diabetes: when one injection is no longer sufficient.
    Garber AJ
    Diabetes Obes Metab; 2009 Nov; 11 Suppl 5():14-8. PubMed ID: 19817779
    [No Abstract]   [Full Text] [Related]  

  • 7. Starting insulin strategies for patients with an inadequate response to oral therapy.
    Rolla AR
    Diabetes Obes Metab; 2009 Nov; 11 Suppl 5():6-9. PubMed ID: 19817777
    [No Abstract]   [Full Text] [Related]  

  • 8. [Analog insulin preparations in patients with type 2 diabetes. Better rapid and brief than sluggish and long].
    MMW Fortschr Med; 2005 Nov; 147(46):60. PubMed ID: 16358638
    [No Abstract]   [Full Text] [Related]  

  • 9. [When oral antidiabetics are no longer enough. Tablets plus basal insulin].
    Meissner T
    MMW Fortschr Med; 2001 Aug; 143(31-32):46. PubMed ID: 11556193
    [No Abstract]   [Full Text] [Related]  

  • 10. [Individualized therapy. Insulin therapy requirements in pregnancy and old age].
    MMW Fortschr Med; 2005 Nov; 147(46):61. PubMed ID: 16358639
    [No Abstract]   [Full Text] [Related]  

  • 11. Use of rapid-acting insulin analogues in the treatment of patients with type 1 and type 2 diabetes mellitus: insulin pump therapy versus multiple daily injections.
    Bode BW
    Clin Ther; 2007; 29 Suppl D():S135-44. PubMed ID: 18191065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin therapy for type 2 diabetes. Getting started.
    Snyder C; Hirsch IB
    Diabetes Self Manag; 2008; 25(4):30, 32-3, 35-6. PubMed ID: 18717025
    [No Abstract]   [Full Text] [Related]  

  • 13. [Insulin and oral antidiabetic drugs. How to combine them in type 2 diabetes?].
    Lotz N
    MMW Fortschr Med; 2000 May; 142(18):45-8. PubMed ID: 10851870
    [No Abstract]   [Full Text] [Related]  

  • 14. Participants' experiences of intensifying insulin therapy during the Treating to Target in Type 2 Diabetes (4-T) trial: qualitative interview study.
    Jenkins N; Hallowell N; Farmer AJ; Holman RR; Lawton J
    Diabet Med; 2011 May; 28(5):543-8. PubMed ID: 21480965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved glycaemic control of thrice-daily biphasic insulin aspart compared with twice-daily biphasic human insulin; a randomized, open-label trial in patients with type 1 or type 2 diabetes.
    Clements MR; Tits J; Kinsley BT; Råstam J; Friberg HH; Ligthelm RJ
    Diabetes Obes Metab; 2008 Mar; 10(3):229-37. PubMed ID: 18269638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Documented advantages of Lantus in comparison with NPH].
    Birgersson MO
    Lakartidningen; 2004 Oct; 101(42):3270, 3273; author reply 3273. PubMed ID: 15544137
    [No Abstract]   [Full Text] [Related]  

  • 17. [Insulin treatment in type 2 diabetes].
    Birkeland KI
    Tidsskr Nor Laegeforen; 2006 Mar; 126(7):919-20. PubMed ID: 16554885
    [No Abstract]   [Full Text] [Related]  

  • 18. How do detemir and glargine compare when added to oral agents in insulin-naïve patients with type 2 diabetes mellitus?
    Koenen C
    Nat Clin Pract Endocrinol Metab; 2008 Oct; 4(10):E1. PubMed ID: 18806804
    [No Abstract]   [Full Text] [Related]  

  • 19. Insulin glargine and glulisine SoloSTAR pens for the treatment of diabetes.
    Garg S; Kelly WC; Garg S
    Expert Rev Med Devices; 2008 Mar; 5(2):113-23. PubMed ID: 18331174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Oral diabetic treatment is no longer enough. Making a successful transition to insulin therapy (interview by Dr. Judith Neumaier)].
    Fritsche A
    MMW Fortschr Med; 2004 May; 146(21):60. PubMed ID: 15373090
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.